Your browser doesn't support javascript.
loading
EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma.
Chemlal, Djamila; Varlet, Emmanuel; Machura, Amelie; Ovejero, Sara; Requirand, Guilhem; Robert, Nicolas; Cartron, Guillaume; Alaterre, Elina; Bret, Caroline; Vincent, Laure; Herbaux, Charles; Cavalli, Giacomo; Bruyer, Angélique; De Boussac, Hugues; Moreaux, Jerome.
Afiliación
  • Chemlal D; Diag2Tec, Montpellier, France.
  • Varlet E; Institute of Human Genetics, UMR CNRS-UM, 9002, Montpellier, France.
  • Machura A; Institute of Human Genetics, UMR CNRS-UM, 9002, Montpellier, France.
  • Ovejero S; Diag2Tec, Montpellier, France.
  • Requirand G; Institute of Human Genetics, UMR CNRS-UM, 9002, Montpellier, France.
  • Robert N; Department of Biological Hematology, CHU Montpellier, Montpellier, France.
  • Cartron G; Department of Biological Hematology, CHU Montpellier, Montpellier, France.
  • Alaterre E; Department of Biological Hematology, CHU Montpellier, Montpellier, France.
  • Bret C; Department of Clinical Hematology, CHU Montpellier, Montpellier, France.
  • Vincent L; University of Montpellier, UFR Medicine, Montpellier, France.
  • Herbaux C; Institute of Human Genetics, UMR CNRS-UM, 9002, Montpellier, France.
  • Cavalli G; Institute of Human Genetics, UMR CNRS-UM, 9002, Montpellier, France.
  • Bruyer A; Department of Biological Hematology, CHU Montpellier, Montpellier, France.
  • De Boussac H; University of Montpellier, UFR Medicine, Montpellier, France.
  • Moreaux J; Department of Clinical Hematology, CHU Montpellier, Montpellier, France.
Leukemia ; 37(9): 1925-1928, 2023 09.
Article en En | MEDLINE | ID: mdl-37532787

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Francia
...